[APLS] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
29-Sep-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -8.49%
YoY- 76.88%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,126 -9,051 -6,620 -7,211 -6,647 -6,647 -6,947 45.01%
Tax -12,138 -9,063 -6,679 -7,234 38 38 1,269 -
NP -12,126 -9,051 -6,620 -7,211 -6,647 -6,647 -8,216 29.66%
Tax Rate - - - - - - - -
Total Cost 12,126 9,051 6,620 7,211 6,647 6,647 8,216 29.66%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.67 -0.50 -0.37 -0.40 -0.79 -0.79 -0.45 30.42%
EPS Diluted -0.67 -0.50 -0.37 -0.40 -0.79 -0.79 -0.45 30.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.